<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02583061</url>
  </required_header>
  <id_info>
    <org_study_id>01-0318-E</org_study_id>
    <nct_id>NCT02583061</nct_id>
  </id_info>
  <brief_title>Toronto Gestational Glucose Tolerance Cohort</brief_title>
  <official_title>Toronto Gestational Glucose Tolerance Cohort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mount Sinai Hospital, Canada</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mount Sinai Hospital, Canada</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this prospective observational cohort study, women representing the full spectrum of
      gestational glucose tolerance status are undergoing longitudinal cardiometabolic
      characterization at regular intervals in the years after the index pregnancy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this prospective observational cohort study, women reflecting the full spectrum of glucose
      tolerance in pregnancy (from gestational diabetes mellitus (GDM) to lesser degrees of
      gestational glucose intolerance to those with completely normal glucose tolerance) are being
      recruited in late 2nd trimester. This cohort of women thus carries a broad range of risk for
      the future development of type 2 diabetes (T2DM) and cardiovascular disease. At regular
      intervals in the years after the index pregnancy, this cohort of women is undergoing serial
      cardiometabolic characterization, including assessment of glucose tolerance, beta-cell
      function and insulin sensitivity. The longitudinal changes over time in this cohort should
      provide insight into the early pathophysiology and natural history of T2DM and cardiovascular
      disease.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2003</start_date>
  <completion_date type="Anticipated">January 2025</completion_date>
  <primary_completion_date type="Anticipated">January 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Glucose tolerance status</measure>
    <time_frame>10 years after pregnancy</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Type 2 Diabetes, Gestational Diabetes, Pre-diabetes</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>There is no intervention. An exposure of interest is glucose tolerance status in pregnancy</intervention_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum and plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The study population consists of pregnant women across the full spectrum of gestational
        glucose tolerance
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women

        Exclusion Criteria:

          -  Pre-existing diabetes before the index pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ravi Retnakaran, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mount Sinai Hospital, New York</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ravi Retnakaran, MD</last_name>
    <phone>416-586-4800</phone>
    <phone_ext>3941</phone_ext>
    <email>rretnakaran@mtsinai.on.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G1X5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ravi Retnakaran, MD</last_name>
      <phone>416-586-4800</phone>
      <phone_ext>3941</phone_ext>
      <email>rretnakaran@mtsinai.on.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 20, 2015</study_first_submitted>
  <study_first_submitted_qc>October 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2015</study_first_posted>
  <last_update_submitted>September 12, 2016</last_update_submitted>
  <last_update_submitted_qc>September 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

